RxDoctor Payments Data

Krista Przybelinski, NP

Adult Health · Westfield, NYNPI 1043647688

Payments from drug & device makers

$531in general payments, 2019–2025

Across 28 payments — averaging $18.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$127
  • Merck$70
  • Pfizer$50
  • Lilly USA, LLC$46
  • GSK$42
  • Boston Scientific$30
  • plus $165 from 10 others

What the payments were for

  • Food & beverage$51797%
  • Education$143%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$531 in reported general payments places this provider in the 55th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$41,309
Medicare patients
141
Services billed
709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$43,155
JardianceEmpagliflozin29$41,479
EliquisApixaban32$40,140
XareltoRivaroxaban19$24,024
TrulicityDulaglutide11$24,007
RybelsusSemaglutide15$23,075
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$11,160
Incruse ElliptaUmeclidinium Bromide15$4,929
Arnuity ElliptaFluticasone Furoate14$2,664
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,155
Atorvastatin Calcium196$1,910
Metoprolol Succinate135$1,809
Albuterol Sulfate HfaAlbuterol Sulfate47$1,729
Celecoxib26$1,478
Levothyroxine Sodium91$1,453

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$127$66,23143 claims
Boehringer IngelheimJardiance$14$41,47929 claims
PfizerEliquis$50$40,14032 claims
Lilly USA, LLCTrulicity$46$24,00711 claims
GSKTrelegy Ellipta, Incruse Ellipta, Arnuity Ellipta$42$18,75342 claims
AbbVieSynthroid$15$1,27211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,828 adult health providers in New York.

Other adult health in Westfield

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →